Dockets
Federal rulemakings, soonest-closing first — each gathers its documents and comments.
DEA ▾
Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017
Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Suspicious Orders of Controlled Substances
Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022
Regulation of Telepharmacy Practice
Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I
Exempt Chemical Preparations Under the Controlled Substances Act (DEA372)
Providing CS to Ocean Vessels, Aircraft, and Other Entities
Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989)
Controlled Substances Ordering System Modernization (DEA732)
Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948)
Telemedicine Prescribing of Controlled Substances (DEA407)